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LKB1 is essential for the proliferation of T-cell
progenitors and mature peripheral T cells
Peter Tama´s1, Andrew Macintyre1, David Finlay1, Rosemary Clarke1,
Carmen Feijoo-Carnero1, Alan Ashworth2 and Doreen Cantrell1
1 Division of Cell Biology and Immunology, School of Life Sciences, University of Dundee,
Dundee, Scotland, United Kingdom
2 The Breakthrough Breast Cancer Centre, the Institute of Cancer Research, London, England,
United Kingdom
The serine/threonine kinase LKB1 has a conserved role in Drosophila and nematodes to
co-ordinate cell metabolism. During T lymphocyte development in the thymus, progeni-
tors need to synchronize increased metabolism with the onset of proliferation and
differentiation to ensure that they can meet the energy requirements for development.
The present study explores the role of LKB1 in this process and shows that loss of LKB1
prevents thymocyte differentiation and the production of peripheral T lymphocytes. We
find that LKB1 is required for several key metabolic processes in T-cell progenitors. For
example, LKB1 controls expression of CD98, a key subunit of the L-system aa transporter
and is also required for the pre-TCR to induce and sustain the regulated phosphorylation
of the ribosomal S6 subunit, a key regulator of protein synthesis. In the absence of LKB1
TCR-b-selected thymocytes failed to proliferate and did not survive. LBK1 was also
required for survival and proliferation of peripheral T cells. These data thus reveal a
conserved and essential role for LKB1 in the proliferative responses of both thymocytes
and mature T cells.
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See accompanying commentary by Aifantis and Sawai
Introduction
T-cell proliferation and differentiation in the thymus and the
periphery are regulated by the pre-TCR, the mature TCR,
cytokines and chemokines [1–3]. These stimuli are linked via
tyrosine kinases to a diverse network of serine/threonine kinases
that regulate the key checkpoints of T-cell proliferation and
differentiation [4–6]. T-cell expansion in the thymus is an energy-
demanding process that only proceeds when extra cellular signals
from Ag receptors, cytokines and stromal cells stimulate sufficient
cellular energy production and nutrient uptake to satisfy the
biosynthetic demands of the activated T cell [7–9]. For example,
during T-cell development in the thymus there is rapid
proliferative expansion of TCR-b selected T-cell progenitors [3].
To meet the increased energy demands of these proliferating
cells, the pre-TCR and Notch induce and then maintain cell
surface expression of nutrient receptors such as aa transporters
and transferrin receptor and also increase the expression of the
glucose transporter. These increases in glucose metabolism and
aa uptake are essential for T-cell development in the thymus. For
example, the serine/threonine kinase phosphoinositide depen-
dent kinase 1 (PDK1) and its substrates protein kinase Ba (PKBa),
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b and g regulate the expression of glucose and aa transporters in
thymocytes. T-cell progenitors that do not express PDK1 or that
lack expression of PKB isoforms fail to express these nutrient
receptors and fail to develop because they cannot meet the
metabolic demands of thymus development [7, 8, 10, 11].
One other serine/threonine kinase that can regulate cellular
responses to energy stress is LKB1 (or serine/threonine kinase 11
-STK11) [12]. This is an evolutionarily conserved kinase: Par4,
the Caenorhabditis elegans ortholog, is one of the six ‘‘partition-
ing’’ molecules that control zygote polarity [13] in Drosophila.
The LKB1 ortholog is required to synchronize cellular energy
checkpoints and cell division [14, 15]. The Drosophila LKB1
homologue is thus essential for mitotic spindle formation,
for the establishment of cell polarity and controlling the
asymmetric division of stem cells [16]. LKB1 also has essential
functions in mice as LKB1 deletion causes problems with
vascular and neural development that result in embryonic leth-
ality at E10-11 [17]. In humans the importance of LKB1 is
highlighted by the fact that it is mutated in a high proportion of
Peutz-Jeghers syndrome patients: Peutz-Jeghers syndrome is
associated with the development of benign hamartomas and an
increased risk of malignant tumor formation [18–20]. LKB1 is
important because it phosphorylates critical activating residues in
the catalytic domains of multiple members of the AMP-activated
protein kinase (AMPK) family including the a1 and a2 isoforms of
AMPK and NUAK1–2, BRSK1-2, QIK, QSK, Salt-inducible kinase
(SIK), MELK and MARK1–4 kinases [21]. The AMPKa1 and a2
are phosphorylated and activated by LKB1 in response to
increases in cellular AMP:ATP ratio. AMPK then act to restore
energy balance in a cell by inhibiting ATP consuming processes
and stimulating ATP generating pathways [22]. SIK and MARK2
also regulate cellular metabolic responses in different tissues
leading to a model whereby LKB1 acts to regulate the energy
status of the cell [23–25]. The significance of LKB1 in energy
checkpoints is illustrated by the fact that loss of LKB1 in fibro-
blasts and in the pancreas is associated with apoptosis in response
to energy stress [26, 27]. There is also evidence that LKB1
controls the induction of autophagy in response to energy
deprivation and sensitizes epithelial cells to c-myc-induced
apoptosis [28, 29].
The role of LKB1 and AMPK family kinases in lymphocytes is
not known but is topical because of the increasing awareness that
energy control and the regulation of asymmetric cell division may
control T lymphocyte fate [11, 30]. In mature T cells, the a1
AMPK isoform is expressed and is activated by TCR triggering via
calcium/calmodulin dependent kinase kinases and by energy
stress, presumably via LKB1 [31]. AMPK a1-null T cells have
increased sensitivity to energy stress but can mount apparently
normal immune responses [32]. There are, however, immune
defects in mice that lack expression of another AMPK family
kinase, MARK2. T cells lacking expression of MARK2 are hyper-
responsive to TCR triggering with increased cytokine production
and MARK2-null mice develop autoimmune disease, indicating
that MARK2 is required for immune homeostasis [33]. Interest-
ingly, neither AMPka1- nor MARK2-null mice have defects in
T-cell development in the thymus [32, 33]. This could indicate
that AMPK family kinases are physiologically irrelevant for T-cell
development but it is perhaps more likely that there is redun-
dancy between different AMPK family members. One experi-
mental strategy that circumvents problems caused by the
existence of multiple redundant kinases is to delete a rate-limit-
ing specific upstream regulator. In the context of the AMPK family
the obvious candidate is LKB1, a ‘‘master kinase’’ that phos-
phorylates and activates multiple AMPK family kinases [21].
Accordingly, the present study reports the impact of T-lineage-
specific deletion of LKB1 and shows that LKB1 has essential
functions for the development of TCR-b selected T-cell progeni-
tors. LBK1 was also required for survival and proliferation of
peripheral T cells revealing that AMPK family kinases control
proliferative checkpoints in thymocyte differentiation and in
peripheral T cells.
Results
Deletion of LKB1 prevents T-cell development
The objective of the present study was to explore the role of LKB1
in T lymphocytes. Mice with floxed LKB1 exons 4–7 on both
alleles (LKB1fl/fl) [34] were backcrossed with mice expressing Cre
recombinase under the control of the proximal p56lck proximal
promoter (Lck-Cre1), which induces Cre expression in T-cell
progenitors in the thymus [35]. The LckCre1LKB1fl/fl mice were
viable, although they had very small thymi (Fig. 1A) that lacked
the normal cortical/medullar architecture (data not shown).
These small LckCre1 LKB1fl/fl thymi contained greatly reduced
numbers of thymocytes compared to LckCre1LKB11/1 controls
(Fig. 1B). To determine which stages of thymocyte development
were sensitive to LKB1 loss, LckCre1LKB1fl/fl thymi were
analyzed for expression of the major histocompatibility complex
(MHC) receptors CD4 and CD8. Early T-cell progenitors are
double negative (DN) for CD4 and CD8. DN progenitors undergo
TCR-b locus rearrangements to produce a TCR-b polypeptide that
permits surface expression of the pre-TCR complex. The pre-TCR
then supports survival and directs rapid clonal expansion along
with differentiation of cells into CD41CD81 double positive (DP)
thymocytes. TCR a-chain gene rearrangements then occur and
cells that express a functional but non self reactive a/b TCR
complex differentiate to either CD41 or CD81 single positive (SP)
T cells [1, 3, 36]. Figure 1C shows that LckCre1LKB1fl/fl thymi
contained mostly DN cells and had very few DP or SP. There were
also very few peripheral T cells present in the blood or spleen of
the LckCre1LKB1fl/fl mice compared to LckCre1 LKB11/1 control
animals (Fig. 1D and E). Moreover, in the few peripheral T cells
of LckCre1LKB1fl/fl mice there was evidence that LKB1 deletion
was not complete, as cells contained non-deleted LKB1 floxed
alleles (Fig. 1F). Initial analysis of LckCre1LKB1fl/fl mice thus
showed that LKB1 is essential for T-cell development in the
thymus; only cells that fail to delete LKB1 can differentiate in the
thymus and generate peripheral T cells.
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DN3/DN4 transition defects in LKB1-null thymocytes
DN thymocytes can be subdivided on the basis of CD44 and CD25
expression: the earliest progenitors are CD441and CD25 DN1),
followed sequentially by the CD441 and CD251 (DN2), CD44
and CD251 (DN3) and CD44CD25 DN4 ) populations [3, 36].
CD25 and CD44 staining profiles showed that LckCre1LKB1fl/fl
thymi had an increased frequency of the DN3 subset: numbers of
DN3 thymocytes were 4.0–9.1106 in LckCre1LKB11/1 while
3.6–7.6106 in LckCre1LKB1fl/fl thymi (Fig. 2A). Moreover,
DN3 cells in LckCre1LKB1fl/fl thymi showed abnormally high
levels of CD25 expression (Fig. 2B). There was no subset of
cells corresponding to WT DN4, i.e. CD44CD25 in LckCre1
LKB1fl/fl thymi although there was a population of CD44
CD25low cells that resembled cells in transition from the DN3 to
DN4 stage. Numbers of DN4 thymocytes were 1.6–3.7 106 in
LckCre1LKB11/1 thymi while the numbers of CD44CD25low
thymocytes were 3.6–7.6 and 0.8–2.1 106 in LckCre1LKB1fl/fl
samples. The first phenotypic difference between LckCre1LKB1fl/fl
and normal thymi is thus seen in DN3 thymocytes; some cells
partially transit to the DN4 stage albeit at lower frequency than
normal. The proximal p56Lck promoter is active in DN1 cells,
although its activation tends to be heterogeneous until the DN3
stage [37]. In this context, genomic PCR analysis indicated partial
deletion of LKB1 in DN3 cells and complete loss in the CD44
CD25low cells (Fig. 2C).
LKB1 is known to phosphorylate and activate AMPK in
response to energy stress ([22, 38]. Therefore to assess functional
loss of LKB1, we compared the ability of 2-deoxyglucose, an
inhibitor of glycolysis that increases cellular ratios of AMP/ATP,
to activate AMPK in control and LckCre1LKB1fl/fl DN thymocytes.
AMPKa1 can also be phosphorylated and activated by calcium/
calmodulin dependent kinase kinases (CaMKK) in T cells [31] so
the effect of the CaMKK inhibitor STO609 on AMPK activation
was also examined. Figure 2D shows that there is low basal
phosphorylation of Thr 172 in the activation loop of AMPKa1 in
WT pre-T cells and that this phosphorylation is increased by 2-DG
treatment. AMPKa1 Thr 172 phosphorylation was not inhibited
by STO609. Basal phosphorylation of AMPKa1 in LckCre1
LKB1fl/fl thymocytes was observed, but this was not increased by
2-DG treatment.
LKB1 and pre-TCR/Notch signaling
CD25 downregulation in DN3 is driven by the pre-TCR [39]. The
high level of CD25 on LckCre1LKB1fl/fl DN3 cells coupled with
the failure of these cells to completely downregulate CD25 and
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Figure 1. Deletion of LKB1 prevents T-cell development (A) Appearance of thymi in LckCre1LKB1fl/fl and LckCre1LKB11/1 mice. (B) Total thymocyte
numbers from 5- to 8-wk-old LckCre1LKB1fl/fl (n5 10) and LckCre1LKB11/1 (n5 10) mice. (C) Flow cytometry of CD4 and CD8 subpopulations in
thymocytes from LckCre1LKB1fl/fl and LckCre1LKB11/1 mice. Dot plots of Thy-1-gated cells are representative of ten independent experiments.
(D) Flow cytometry of T cell (TCRb1) and B cell (B2201) subpopulations in blood from LckCre1LKB1fl/fl and LckCre1LKB11/1 mice. Dot plots
are representative of three independent experiments. Gates show T and B cell populations. (E) Total numbers of T lymphocytes in spleens from
LckCre1LKB1fl/fl (n5 5) and LckCre1LKB11/1 (n5 5) mice. (F) Genomic PCR analysis of the fl/fl LKB1 gene in T lymphocytes from spleen indicating
that peripheral T cells have not deleted the LKB1 allele.
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complete transit to DN4 cells could thus reflect a problem with
pre-TCR expression or function. The rate-limiting step for pre-
TCR expression is normally the TCR b locus rearrangement [40].
However, analysis of intracellular TCR-b expression showed that
LckCre1LKB1fl/fl DN3 cells had successfully rearranged their
TCR-b locus and expressed intracellular TCR subunits at the
normal frequency (approximately 15%) (Fig. 3A). It was also
seen that the subpopulation of LKB1-null pre-T cells that had
partially downregulated CD25 were predominantly TCR-b
selected (80%) and in this regard were indistinguishable from
bona fide WT DN4 (Fig. 3A).
One difference between WT and LKB1 deleted DN3 cells is
that the latter have increased expression of CD25, a phenotype
that frequently results from defective pre-TCR signal transduc-
tion. We therefore examined a range of pre-TCR-induced
responses in LckCre1LKB1fl/fl pre-T cells. One key function of the
pre-TCR is to drive cell cycle progression as cells transit from DN3
to DN4. Flow cytometric analysis of cellular DNA content showed
that LKB1 loss did not block cell cycle entry, as LKB1-null pre-T
cells can enter the proliferative S/G2 phases of the cell cycle
albeit at a reduced frequency compared to controls (Fig. 3B). Pre-
TCR signaling also induces expression of key nutrient receptors
on T-cell progenitors, namely CD71 the transferrin receptor and
CD98, a subunit of the L-aa transporter [7]. LKB1 loss had no
impact on surface expression of CD71 the transferrin receptor but
there was a striking decrease in the surface expression of CD98 aa
transporter in LckCre1LKB1fl/f pre-T cells (Fig. 3C).
We also analyzed the effect of LKB1 deletion on pre-TCR-
induced phosphorylation (Ser235/236) of the S6 ribosomal
subunit by the 70 kDa ribosomal S6 kinases. S6 phosphorylation
can be quantified directly ex vivo by flow cytometry and intra-
cellular staining of fixed cells with specific phospho-S6 antisera
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[10]. WT DN3 thymocytes analyzed immediately ex vivo are
heterogeneous for phosphoS6: the majority of cells are phos-
phoS6low but 15–20% are phosphoS6high corresponding to cells
that have rearranged their TCR-b subunit to express the pre-TCR.
DN4 thymocytes are primarily phosphoS6high (Fig. 3D). The data
show severely reduced phosphorylation of S6 in LckCre1LKB1fl/fl
stained DN thymocytes. S6 phosphorylation is induced by
PDK1/PKB signaling pathways initiated by the pre-TCR and
sustained by stromal signals such as Notch ligands [41]. In this
respect, LKB1-null T cells had normal expression of CD71, the
transferrin receptor. This is relevant because CD71 expression in
T-cell progenitors is controlled by pre-TCR/Notch-induced PDK1/
PKB-mediated pathways [7]. The normal expression of CD71 is
thus evidence for functioning PKB signaling in LKB1-null pre-
T cells. We further explored the impact of LKB1 on pre-TCR
signaling by examining expression of known pre-TCR-induced
genes, such as CD2 and CD5 and Nurr77 [7, 42, 43]. LKB1-null
DN4 pre-T cells expressed lower levels of CD2 mRNA than
controls and there was also a small but reproducible decrease in
expression of CD5 mRNA. However, the expression of Nur77, also
a pre-TCR-induced gene, was not changed (Fig. 3E). The results
argue that LKB1 loss causes selective defects but not global
problems with pre-TCR signal transduction. We also examined
the expression of Notch target genes, Hes-1 and Deltex-1[44], in
pre-T cells isolated ex vivo from control or LckCre1LKB1fl/fl mice.
The CD44CD25low cells from LckCre1LKB1fl/fl mice expressed
increased levels of Hes-1 and Deltex1 when compared with
control cells (Fig. 3E). The expression of these Notch target genes
in LKB1-null pre-T cells argues that these cells are responding to
Notch ligands in vivo.
LKB1 is required for survival of TCR-b selected T-cell
progenitors
The differentiation and proliferation of b selected pre-T cells in
the thymus is dependent on sustained Notch receptor/ligand
interactions [8, 41, 45]. To explore further impact of LKB1
deletion on thymocyte development, we compared the responses
of pre-T cells from control or LckCre1LKB1fl/fl mice in an in vitro
system that uses OP9 stromal cells expressing the Notch ligand
delta-like 1 (OP9-DL1) and IL-7 to support survival, proliferation
and differentiation of T-cell progenitors [46]. In initial experi-
ments we compared the responses of cells maintained on the
OP9-DL1 cells in both the presence and absence of IL-7. As
described previously, normal DN thymocytes (LckCre1LKB11/1)
undergo proliferative expansion when cultured on OP9-DL1 cells
and this proliferative response is enhanced by the addition
of IL-7 [47] (Fig. 4A). In contrast, LKB1-null DN thymocytes
(LckCre1LKB1fl/fl) did not proliferate on OP9-DL1 cells. The
addition of IL-7 to the cultures caused a small improvement to the
proliferative response of the LKB1-null DN thymocytes, indicating
that the cells had not lost the capacity to respond to IL-7 but the
cells still failed to undergo proliferative expansion in these in
vitro models. Moreover, the proliferative expansion of normal
TCR-b selected DN4 (LckCre1LKB11/1) is followed by their
differentiation to DP thymocytes. Strikingly, TCR-b selected
CD44CD25lowLckCre1LKB1fl/fl thymocytes do not differentiate
to DP on OP9-DL1 cells (Fig. 4B), in fact they die. LKB1-null pre-
T cells thus rapidly acquire the light scattering profiles of dead
cells rather than viable cells (Fig. 4C). LKB1-null pre-T cells also
show a rapid decrease in plasma membrane integrity (Fig. 4D)
and a high frequency of cells with a sub-G1 DNA content,
indicative of DNA degradation (Fig. 4E). LKB1 is thus essential
for the survival of TCR-b selected T-cell progenitors as they
proliferate and differentiate in response to Notch ligands and
IL-7.
LKB1 is required for survival of proliferating peripheral
T cells
Does this requirement for LKB1 support the proliferation of T-cell
progenitors unique to this T-cell subpopulation? To address this
question we examined the LKB1 requirement for the proliferative
responses of mature T cells. In these experiments we bypassed the
LKB1 requirement for T-cell development by breeding mice
expressing LKB1 floxed alleles to CreERT2 mice that express a
tamoxifen inducible Cre recombinase. In initial experiments,
CreERT2LKB11/1 and CreERT2LKB1fl/fl peripheral T cells were
polyclonally activated with CD3 Ab and maintained in exponential
proliferation in vitro by the addition of IL-2. T cells were then
treated with 4-hydroxytamoxifen (4OHT) to induce deletion of
LKB1 in the CreERT2LKB1fl/fl cells. The data (Fig. 5A) confirmed
deletion of LKB1 following 4OHT treatment of CreERT2LKB1fl/fl
peripheral T lymphoblasts and revealed that LKB1 deletion
stopped the proliferation of T cells and resulted in cell death
(Fig. 5B and C). In further experiments, peripheral primary T cell
isolated from CreERT2LKB11/1 and CreERT2LKB1fl/fl mice were
cultured in IL-7 in the presence of 4OHT. Thereafter cells were
stimulated with CD3/CD28 Ab coated beads to induce prolifera-
tion. The data in Fig. 5D show that 4OHT treated control
lymphocytes from CreERT2 mice (CreERT2LKB11/1) gave a robust
proliferative response following CD3/CD28 stimulation whereas
CreERT2LKB1fl/fl T cells did not. Both cell populations could be
maintained with comparable viability when cultured in IL-7
(Fig. 5E) but the viability of the CD3/CD38 triggered LKB1-null
cells were markedly reduced compared with the control LKB1
WT cells (Fig. 5E). These data show that LKB1 is required to
support the survival of mature T cells when they are induced to
proliferate.
Discussion
The present results establish that LKB1 has critical functions
during T-cell development. In the thymus LKB1 is required for the
survival and differentiation of TCR-b selected T-cell progenitors.
T-cell progenitors that successfully rearrange their TCR-b and
express the pre-TCR complex normally proliferate rapidly prior to
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differentiation to the DP stage of thymus development. The
present data now show that LKB1-null pre-T cells that have
rearranged their TCR-b locus are unable to proliferate and
undergo cell death rather than complete their normal program of
development. The data also show that LKB1-null peripheral
T cells are unable to proliferate and undergo cell death in
response to CD3/CD28 stimulation. Activated T cells maintained
in culture with IL-2 similarly fail to proliferate and die following
LKB1 loss. It is well established that cells that fail to match energy
production to energy demands die by apoptosis. LKB1 thus
appears to coordinate the ability of T cells to match energy
production to the energy requirements for the proliferative burst
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that accompanies TCR-b selection or the immune activation/
cytokine-induced proliferation of peripheral T cells.
LKB1 phosphorylates and activates multiple members of
the AMPK family including the a1 and a2 isoforms of AMPK,
NUAK1-2, BRSK1-2, QIK, QSK, SIK, MELK and MARK1–4 kinases
[21]. There have been some studies to probe the role of indivi-
dual members of this kinase family in T cells. For example, AMPK
a1-null T cells have increased sensitivity to energy stress [32] and
there are defects in immune homeostasis in mice that lack
expression of another AMPK family kinase, MARK2/Par-1b [33].
However, neither the AMPK a1 nor MARK2 mice showed any
evidence for defective thymus development [32, 33]. This could
mean that there is redundancy between members of the AMPK
family in T cells. In this respect, redundancy between different
serine/threonine kinases has been seen previously in T lympho-
cytes. For example, T cells express three isoforms of PKB/Akt and
unveiling of the function of these kinases in vivo in the thymus
required simultaneous deletion of all three isoforms [48]. There
is also redundancy between different isoforms of PI3K in T-cell
progenitors such that deletion of both the p110 delta and p110
gamma catalytic subunits of PI3K is required to reveal the
importance of PI3K in T-cell progenitors [49]. The impact of
LKB1 deletion versus deletion of individual AMPK family kinases
is an indication that there is similar redundancy between differ-
ent members of the AMPK family in T cells.
Previous studies have focused extensively on the role of PI3K
and the serine/threonine kinases PKB/Akt in the control of T-cell
metabolism [50].The present data showing that LKB1, a kinase
that evolved to couple energy metabolism and cell differentiation,
also has essential functions in T lymphocytes. It reveals that
T cells use multiple pathways to deal with the metabolic stress of
proliferation. Here it is important to note that these two kinase
pathways function in quite different modes. In T cells, PKB/Akt
activity is controlled directly by Ag receptors/costimulatory
molecules and or cytokines and the level of Akt activity is
determined by cellular levels of Phosphatidyinositol (3,4,5) tris
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phosphate and the activity of PDK1 and mTOR (mammalian
target of rapamycin) [51]. In contrast, LKB1 signaling pathways
are not coupled directly to extracellular stimuli but rather act
homeostatically in response to energy stress to restore energy
balance. For example, LKB1 acts as a rheostat for cellular AMP/
ATP ratios and phsophorylates and activates AMPK when cellular
levels of ATP drop. This concept of how LKB1 works explains why
it is not possible to explain the phenotype of LKB1-null T cells by
the loss of a linear biochemical signaling pathway that is coupled
to a single receptor. Rather LKB1 is integral to the control of
T-cell proliferation irrespective of the proliferative stimulus.
Materials and Methods
Mice
Mice (5–7 weeks old) were maintained in SPF conditions at the
University of Dundee under Home Office project license PPL60/
3116. C57BL/6-Gt(ROSA)26Sor tm9(cre/Esr1)Arte mice
carrying a transgene in the ROSA locus encoding for a
ubiquitously expressed Cre recombinase/modified oestrogen
receptor fusion protein CreERT2, were purchased from Taconic-
Artemis. LKB1fl/fl mice were generated and bred as previously
described [34]. LKB1fl/fl mice were crossed either to transgenic
mice expressing Cre recombinase under the T-cell-specific Lck
promoter [35] or to CreERT2 mice. Genotyping was performed by
PCR using genomic DNA isolated from ears. The presence
of a WT or floxed LKB1 allele was detected using two
primers: 50-CCAGCCTTCTGACTCTCAGG-30 and 50-GTAGG-
TATTCCAGGCCGTCA-30. PCR amplification of the WT or the
floxed LKB1 alleles resulted in 200-bp and 250-bp PCR products,
respectively. For the detection of Cre (either LckCre or CreERT2),
the following primers were employed: 50-AAATGGTTTCCCGCA-
GAACC-30 and 50-TAGCTGGCTGGTGGCAGATG-30. Cre-mediated
deletion of the floxed LKB1 allele was proved by PCR
using primers: 50-CAGGTTCAGCAGAATCAC-30 and 50-GGGAA-
GAAGGCGATATAAGG-30.
Flow cytometric analysis
Characterization of different thymocyte subpopulations was
performed as described previously [7]. Briefly, Ab conjugated
to fluorescein isothiocyanate, phycoerythrin, allophycocyanin
and biotin were obtained from either Pharmingen (San Diego,
CA, USA) or eBioscience (San Diego, CA, USA). TriColour-
conjugated Ab were obtained from Caltag (Burlingame, CA,
USA). Cells were stained for surface expression of the following
markers using the Ab in parentheses: CD4 (RM4-5), CD8 (53-
6.7), CD25 (7D4), CD44 (IM7), CD98 (RL388), CD71 (C2),
Thy1.2 (53-2.1), TCR-b (H57-597), B220 (RA3-6B2) and
TCR/ (GL3). Cells were stained with saturating concentrations
of Ab in accordance with the manufacturer’s instructions.
Data were acquired on either a FACS Calibur (Becton Dickinson,
Franklin Lakes, NJ, USA) or a LSR1 flow cytometer (Becton
Dickinson) using CellQuest software and were analyzed
using either CellQuest (Becton Dickinson) or FlowJo (Treestar,
San Carlos, CA, USA) software. Viable cells were gated
according to their forward scatter and side scatter profiles.
CD4 and CD8 DN subsets were gated by lineage exclusion
(lineage) of all CD41, CD81 DP and SP cells and TCR-g1. DN3
and DN4 were further defined as CD251CD44 and
CD25CD44 thymocytes, respectively. Mature SP thymocytes
were defined as Thy-11, TCR-bhi and positive for either CD4
or CD8 expression. Cell death was analyzed by staining with
7-aminoactinomycin D (5 mg/mL).
Cell Purification
DN3 and DN4 thymocytes were purified by first depleting thymic
populations of CD41 and CD81 cells using an AutoMACs
magnetic cell sorter (Miltenyi Biotech, Auburn, CA, USA) before
sorting to a purity greater than 95%, using a FACS VantageSE cell
sorter (Becton Dickinson). Peripheral T lymphocyes (from
spleen) were purified by AutoMACS magnetic cell sorter
(Miltenyi Biotech) using mouse pan T-cell isolation kit.
Intracellular TCR-b staining
Intracellular TCR-b staining was performed as described previously
[10]. Briefly: thymocytes were stained for cell surface markers to
define DN3 and DN4 subsets. After fixation in 1% paraformaldehyde
for 10 min at 251C, cells were washed in PBS and permeabilized for
10 min at room temperature in saponin buffer (0.5% (weight/
volume) saponin, 5% FBS and 10 mM HEPES, pH 7.4, in PBS)
Permeabilized cells were incubated for 45 min with phycoerythrin-
conjugated Ab to TCR in saponin buffer, were washed in saponin
buffer and were analyzed on a FACS Calibur. Cell surface binding
sites were blocked by biotinylated TCR and the specificity of staining
was controlled by parallel staining with phycoerythrin-conjugated
isotype-matched control Ab (Armenian hamster IgG2).
Intracellular phospho-S6 staining
Intracellular phosphoS6 staining was performed as described
previously [10]. Thymocytes were treated with 20 nM rapamycin
or were left untreated for 20 min at 371C. Treatment of cells
with rapamycin inhibits the activity of mTor and rapidly reverses S6
(Ser 235/236) phosphorylation. Phospho-S6 staining of rapamycin-
treated cells thus provides an internal negative control as
a standard for each sample. Cells were washed and stained with
surface markers to define the DN3 and DN4 subsets, then were fixed
in 0.5% paraformaldehyde for 15 min at 371C, followed by 15 min
in 90% methanol on ice. After fixation, cells were washed twice in
BSA buffer (0.5% BSA in PBS), then blocked for 10 min at 251C in
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BSA buffer. Cells were incubated for 30 min at 251C with Ab to
phospho-S6 (2211; Cell Signaling Technologies) in BSA buffer, then
were washed and incubated for 30 min at 251C with FITC-
conjugated donkey IgG Ab to rabbit (Jackson ImmunoResearch).
Samples were washed in BSA buffer and were analyzed on a FACS
Calibur.
Cell cycle analysis
The cellular DNA content of DN3 and DN4 thymocytes was
analyzed on live cells, with Hoechst-33342 (Molecular Probes)
staining. Cells were incubated for 1 h at 371C in 5 mg/mL Hoechst-
33342 in 2% FBS DMEM and then were surface stained for CD25,
Thy-1 and lineage markers (including CD44). Samples were
analyzed on an LSR1 flow cytometer eliminating doublets from
the analysis.
Quantitative RT-PCR
DN3 and DN4 Cells (0.5 106 per sample) were lysed for RNA
isolation using the QIAshredder homogenizer (QIAGEN). RNA was
purified with the RNeasy Mini, RNA isolation kit (QIAGEN)
following the manufacturer’s protocol and including an on-column
DNase digestion step with the RNase-free DNase set (QIAGEN).
cDNA was generated using the iScriptTM cDNA synthesis kit (BIO-
RAD). Real-time PCR reactions were performed in a 20mL mixture
containing 1 iQTM SYBR Green supermix (BIO-RAD), 1mL of
cDNA preparation and 0.4mM forward and reverse primers. Real-
time quantitations were performed using the BIO-RAD iCycler iQ
system and using 18S rRNA as an internal control. The primer
sequences for the PCR were as follows
Hes1 Forward 50-ACCTTCCAGTGGCTCCTC-30
Reverse 50-TTTAGTGTCCGTCAGAAGAGAG-30
CD2 Forward 50-GTATGAGGTCTTAGCAAACGGATC-30
Reverse 50-TGTGCCATACACCATTACATTATAGG-30
Nur77 Forward 50-CCTGTTGCTAGAGTCTGCCTTC-30
Reverse 50-CAATCCAATCACCAAAGCCACG-30
Deltex1 Forward: 50-CTTCTGCTACCTCATCTACTTCAA-30
Reverse: 50-GGAATGGAGCCGACAGTGAG-30
18S Forward 50-ATCAGATACCGTCGTAGTTCCG-30
Reverse 50 TCCGTCAATTCCTTTAAGTTTCAGC-30
Cell culture
OP9 bone marrow stromal cells expressing OP9-DL1 and control
OP9 cells were a gift from Juan Carlos Zu´n˜iga-Pflu¨cker (Toronto,
Canada) [46]. OP9 cells were maintained in aMEM supplemented
with 50mM 2-mercaptoethanol, 100 U/mL penicillin, 1 mg/mL
streptomycin and 20% heat-inactivated FBS. DN thymocytes were
co-cultured on OP9-DL1 monolayers for times indicated in figure
legends in the presence or absence of 5 ng/mL of IL-7 as indicated.
For harvesting, thymocytes were filtered through 50mm filters to
remove OP9-DL1 cells before developmental progression of
T lineage cells was assessed. For activation of primary T cells
spleens or lymph nodes were removed from CreERT2LKB11/1 and
CreERT2LKB1fl/fl mice, disaggregated and red blood cells were lysed.
Cells were cultured in RPMI-1640 medium containing L-glutamine
(Invitrogen), 10% v/v heat-inactivated FBS (Gibco), 50mM
b-mercaptoethanol (Sigma) and penicillin–streptomycin (Gibco).
Single-cell suspensions from lymph node preparations
cultured at 5 106 cells per mL. Cells were treated with 0.6 mM
4OHT in the presence of 5 ng/mL IL-7 for 4 days. Thereafter cells
were either stimulated with CD3/CD28 Ab-coated beads (Dyna-
beads Mouse CD3/CD28T cell expander, Invitrogen) or left in
5 ng/mL IL-7 for 3 days.
For the generation of lymphoblasts, mouse CD81 T cells were
cultured for 48 h in the presence of a CD3 Ab (5mg/mL; 145-
2C11; R&D Systems) to trigger the TCR. Thereafter the cells were
washed and maintained in exponential proliferation with 20 ng/
mL IL-2 (Chiron) for another 2 days. Then the cells were treated
with 0.4 mM 4OHT for 3 days. The 4OHT was washed and the cell
proliferation was investigated in the presence of IL-2.
Western blot analysis
Sorted DN4 thymocytes or peripheral T lymphoblasts were lysed
on ice in NP-40 lysis buffer (50 mM HEPES (pH 7.4), 75 mM
NaCl, 1% Nonidet P-40, 10 mM sodium fluoride, 10 mM
iodoacetamide, 1 mM EDTA, 40 mM b-glycerophosphate,
protease inhibitors, 100mM sodium orthovanadate). Lysates were
centrifuged at 1600 g for 15 min at 41C. Protein samples were
separated by SDS NuPAGE 4–12% Bis-Tris PAGE (Invitrogen)
transferred to nitrocellulose membrane and detected by Western
blot analysis using standard techniques. The phosphorylated
AMPK (phospho-172Thr-AMPK Rabbit mAb (Cell Signaling
Technology) and a1 AMPK antisera were used as described
[31]. The LKB1 Ab from Cell Signaling Technology was used to
probe for LKB1 expression.
Statistical analysis
Statistical analyses were performed using GraphPad Prism 4.00
for Macintosh, GraphPad Software. A non-parametric
Mann–Whitney test was used where the number of experiments
performed was not sufficient to prove normal distribution. When
comparing gene expression between LckCre1LKB11/1 and
LckCre1LKB1fl/fl animals, a Student’s t-test was used with the
theoretical mean of LckCre1LKB11/1 sample set to 1. Differences
were considered as significant if po0.05.
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